What is the treatment for olecranon bursitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Olecranon Bursitis

The first-line treatment for olecranon bursitis is conservative management including rest, activity modification, ice application, and NSAIDs, with more invasive interventions reserved for persistent or recurrent cases. 1

Conservative Management (First-Line)

Non-pharmacological Approaches

  • Rest and activity modification, including avoiding pressure on the affected elbow 1
  • Use of open-backed elbow protection to reduce pressure on the affected area 1
  • Ice application through a wet towel for 10-minute periods to reduce swelling and pain 1
  • Radiographs are recommended as the initial imaging modality to exclude fractures, dislocations, or bony abnormalities 2, 1

Pharmacological Approaches

  • NSAIDs such as naproxen are indicated for the relief of signs and symptoms of bursitis 3
  • The recommended dose for acute bursitis is naproxen 500 mg initially, followed by 500 mg every 12 hours or 250 mg every 6-8 hours as required 3
  • The initial total daily dose should not exceed 1250 mg of naproxen, with subsequent daily doses not exceeding 1000 mg 3
  • Topical NSAIDs may be effective with fewer systemic side effects 1
  • Use the lowest effective dose for the shortest duration consistent with treatment goals 3

Second-Line Interventions

For Persistent or Recurrent Cases

  • Immobilization with a splint or brace may be beneficial for acute or refractory cases 1
  • Bursal aspiration may be considered, though it carries a risk of complications 4
  • Corticosteroid injections should be used cautiously as they are associated with significant risks including infection, skin atrophy, and chronic local pain without improving outcomes 5, 4

Surgical Management

  • Surgical intervention should be reserved for cases that fail conservative management 1, 6
  • Nonsurgical management has been shown to be significantly more effective and safer than surgical management 4
  • When surgery is necessary, arthroscopic approaches are increasingly considered as they avoid wound problems often occurring following open excision 6
  • Newer techniques such as hydrothermal ablation (irrigation with heated saline at 50-52°C) may be a safe alternative for recurrent or chronic cases with fewer complications than open bursectomy 7

Special Considerations

Cardiovascular Risk

  • For patients with cardiovascular disease or risk factors, follow a stepped care approach starting with acetaminophen or non-acetylated salicylates before considering NSAIDs 2
  • When NSAIDs are necessary for these patients, use the lowest effective dose for the shortest duration 2, 3

Elderly Patients

  • Lower doses of NSAIDs should be considered in elderly patients as the unbound plasma fraction of naproxen is increased in the elderly 3
  • It is prudent to use the lowest effective dose in elderly patients 3

Renal Impairment

  • Naproxen is not recommended for use in patients with moderate to severe renal impairment (creatinine clearance < 30 mL/min) 3

Treatment Algorithm

  1. Begin with rest, activity modification, ice application, and over-the-counter NSAIDs 1
  2. If symptoms persist, consider prescription-strength NSAIDs at appropriate dosing 3
  3. For refractory cases, consider immobilization with a splint or brace 1
  4. Aspiration may be considered but does not increase risk of infection in aseptic bursitis 4
  5. Avoid corticosteroid injections when possible due to increased complication rates 5, 4
  6. Reserve surgical management for cases that fail all conservative measures 1, 6, 4

References

Guideline

Treatment of Olecranon Bursitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of olecranon bursitis: a systematic review.

Archives of orthopaedic and trauma surgery, 2014

Research

Diagnosis and management of olecranon bursitis.

The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.